Examines the role of the ANS in the maintenance and control of bodily homeostasis, as well as in the pathogenesis, pathophysiology, and treatment of disorders such as cardiovascular disease, hypertension, asthma, arrhythmia, diabetes, ischemia, myocardial infarction, urinary retention, and depression.

Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally. Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes. Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.